C
Caribou Biosciences, Inc.
CRBUHealth Care· Berkeley, CA, US
LAYOFFS TRACKED
1
LAST EVENT
—
MARKET CAP
$52.77M
as of Oct 26, 2026
EMPLOYEES
200
Caribou Biosciences is a genome editing company developing CRISPR-based cellular therapies and agricultural applications. The company focuses on next-generation CRISPR technologies to create engineered cell therapies for oncology and other diseases as well as partnerships for agricultural traits.
Layoff timeline
1 EVENTStories from here
No one has shared a story from Caribou Biosciences yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →Get alerts for Caribou Biosciences
We'll email you the moment a new layoff is reported here.